Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of Naturally Occuring Mixed Astigmatism Up To 6.0 D

NCT00761826 is registered in ClinicalTrials.gov with Carl Zeiss Meditec, Inc. as lead sponsor.

NCT NCT00761826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00761826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of Naturally Occuring Mixed Astigmatism Up To 6.0 D
Lead sponsor
Carl Zeiss Meditec, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
126 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mixed astigmatism